Skip to main content
ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.230
+0.120 (2.92%)
At close: Mar 9, 2026, 4:00 PM EDT
4.230
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT

ADC Therapeutics Revenue

ADC Therapeutics had revenue of $16.43M in the quarter ending September 30, 2025, a decrease of -11.03%. This brings the company's revenue in the last twelve months to $75.21M, up 6.35% year-over-year. In the year 2024, ADC Therapeutics had annual revenue of $70.84M with 1.84% growth.

Revenue (ttm)
$75.21M
Revenue Growth
+6.35%
P/S Ratio
6.80
Revenue / Employee
$283,808
Employees
265
Market Cap
521.52M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202470.84M1.28M1.84%
Dec 31, 202369.56M-140.35M-66.86%
Dec 31, 2022209.91M175.99M518.89%
Dec 31, 202133.92M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CorMedix 311.71M
Zevra Therapeutics 84.39M
Invivyd 53.43M
Prothena Corporation 9.68M
Ocugen 4.41M
Allogene Therapeutics 22.00K
Revenue Rankings

ADCT News

More News